Provided by Tiger Fintech (Singapore) Pte. Ltd.

CytomX Therapeutics

2.64
+0.240010.00%
Post-market: 2.650.0100+0.38%18:59 EDT
Volume:3.41M
Turnover:8.89M
Market Cap:415.92M
PE:5.44
High:2.71
Open:2.46
Low:2.43
Close:2.40
Loading ...

AMGN Posts Upbeat Data on Uplizna From Myasthenia Gravis Study

Zacks
·
18 Mar

Allogene's Q4 Loss Narrower Than Expected, Revenues Nil

Zacks
·
14 Mar

CytomX Therapeutics (CTMX) Upgraded to Strong Buy: Here's What You Should Know

Zacks
·
12 Mar

CytomX Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
08 Mar

CytomX Therapeutics Faces Critical Challenges in Product Development and Market Viability

TIPRANKS
·
08 Mar

CytomX Therapeutics’ Earnings Call Highlights Progress and Challenges

TIPRANKS
·
08 Mar

CytomX Therapeutics, Inc. (CTMX): Among the Cheap Growth Stocks to Buy Now

Insider Monkey
·
08 Mar

Q4 2024 CytomX Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
07 Mar

Cautious Outlook for CytomX Therapeutics Amid Pipeline Challenges and Strategic Setbacks

TIPRANKS
·
07 Mar

Barclays Remains a Buy on CytomX Therapeutics (CTMX)

TIPRANKS
·
07 Mar

CytomX Therapeutics Inc (CTMX) Q4 2024 Earnings Call Highlights: Strategic Advances and ...

GuruFocus.com
·
07 Mar

CytomX Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
07 Mar

CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates

Zacks
·
07 Mar

CytomX Therapeutics Q4 GAAP EPS $0.23 Beats $(0.20) Estimate, Sales $38.09M Beat $19.42M Estimate

Benzinga
·
07 Mar

CytomX Therapeutics Inc -Maintained Financial Strength With Cash Runway Into Q2 2026

THOMSON REUTERS
·
07 Mar

CytomX Therapeutics FY Operating Income USD 24.995 Million

THOMSON REUTERS
·
07 Mar

CytomX Therapeutics Announces 2024 Financial Results and Provides Business Update

GlobeNewswire
·
07 Mar

CytomX Therapeutics to Present at the Barclays 27th Annual Global Healthcare Conference

GlobeNewswire
·
05 Mar

CytomX Therapeutics Inc expected to post a loss of 20 cents a share - Earnings Preview

Reuters
·
05 Mar

CytomX Gears Up to Report Q4 Earnings: What Should Investors Expect?

Zacks
·
04 Mar